{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:30:38Z","timestamp":1785796238758,"version":"3.56.0"},"reference-count":17,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T00:00:00Z","timestamp":1510272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Essential tremor is characterized by persistent, usually bilateral and symmetric, postural or kinetic activation of agonist and antagonist muscles involving either the distal or proximal upper extremity. Quality of life is often affected and one\u2019s ability to perform daily tasks becomes impaired. Oral therapies, including propranolol and primidone, can be effective in the management of essential tremor, although adverse effects can limit their use and about 50% of individuals lack response to oral pharmacotherapy. Locally administered botulinum toxin injection has become increasingly useful in the management of essential tremor. Targeting of select muscles with botulinum toxin is an area of active research, and muscle selection has important implications for toxin dosing and functional outcomes. The use of anatomical landmarks with palpation, EMG guidance, electrical stimulation, and ultrasound has been studied as a technique for muscle localization in toxin injection. Earlier studies implemented a standard protocol for the injection of (predominantly) wrist flexors and extensors using palpation and EMG guidance. Targeting of muscles by selection of specific activators of tremor (tailored to each patient) using kinematic analysis might allow for improvement in efficacy, including functional outcomes. It is this individualized muscle selection and toxin dosing (requiring injection within various sites of a single muscle) that has allowed for success in the management of tremors.<\/jats:p>","DOI":"10.3390\/toxins9110365","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T11:12:26Z","timestamp":1510312346000},"page":"365","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Botulinum Toxin in Management of Limb Tremor"],"prefix":"10.3390","volume":"9","author":[{"given":"Elina","family":"Zakin","sequence":"first","affiliation":[{"name":"Department of Neuromuscular Medicine, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Simpson","sequence":"additional","affiliation":[{"name":"Department of Neuromuscular Medicine, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,11,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Samotus, O., Rahimi, F., Lee, J., and Jog, M. (2016). Functional Ability Improved in Essential Tremor by IncobotulinumtoxinA Injections Using Kinematically Determined Biomechanical Patterns\u2014A New Future. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0153739"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s11940-013-0239-4","article-title":"Update on treatment of Essential Tremor","volume":"15","author":"Zesiewicz","year":"2013","journal-title":"Curr. Treat. Options Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Rajput, A. (2014). Medical Treatment of Essential Tremor. J. Cent. Nervous Syst. Dis., 29.","DOI":"10.4137\/JCNSD.S13570"},{"key":"ref_4","first-page":"567","article-title":"The safety and efficacy of thalamic deep brain stimulation in essential tremor: 10 years and beyond","volume":"85","author":"Kagnoff","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1212\/WNL.41.8.1185","article-title":"Botulinum toxin treatment of tremors","volume":"41","author":"Jankovic","year":"1991","journal-title":"Neurology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/mds.870090604","article-title":"Botulinum toxin a injections for the treatment of hand tremors","volume":"9","author":"Trosch","year":"1994","journal-title":"Mov. Disord."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/mds.870110306","article-title":"A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor","volume":"11","author":"Jankovic","year":"1996","journal-title":"Mov. Disord."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s100720070049","article-title":"Botulinum toxin treatment for functional disability induced by essential tremor","volume":"21","author":"Pacchetti","year":"2002","journal-title":"Neurol. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1212\/WNL.56.11.1523","article-title":"A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor","volume":"56","author":"Brin","year":"2001","journal-title":"Neurology"},{"key":"ref_10","first-page":"S170","article-title":"Injection techniques for Botulinum Toxin Using Electromyography and Electrical Stimulation","volume":"6","year":"1997","journal-title":"Muscle Nerve Suppl."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.5334\/tohm.240","article-title":"Effective Management of Upper Limb Parkinsonian Tremor by IncobotulinumtoxinA Injections Using Sensor-based Biomechanical Patterns","volume":"30","author":"Rahimi","year":"2015","journal-title":"Tremor Other Hyperkinet. Mov."},{"key":"ref_12","unstructured":"Jog, M., Lee, J., Althaus, M., Scheschonka, A., Dersch, H., Team, E.T., and Simpson, D. (2017, January 4\u20138). Efficacy and Safety of incobotulinumtoxinA (Inco\/A) for Essentia Tremor of the Upper Limb using Kinematics-guided clinical decision support: A randomized, double-blind, placebo-controlled trial. Proceedings of the Movement Disorders Society Meeting, Vancouver, BC, Canada."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/mus.880160913","article-title":"Quantifying how location and dose of botulinum toxin injections affect muscle paralysis","volume":"16","author":"Shaari","year":"1993","journal-title":"MuscVe\u0301sinet Nerve"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1212\/01.wnl.0000311389.26145.95","article-title":"Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"70","author":"Simpson","year":"2008","journal-title":"Neurology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/mds.20338","article-title":"Erratum: Botulinum toxin type a therapy during pregnancy. Mov. Disord. 2004, 19, 1384\u20131385","volume":"20","author":"Newman","year":"2005","journal-title":"Mov. Disord."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.clinthera.2007.04.015","article-title":"Formation of neutralizing antibodies in patients receiving botulinum toxin type a for treatment of poststroke spasticity: A pooled-data analysis of three clinical trials","volume":"29","author":"Yablon","year":"2007","journal-title":"Clin. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1468-1331.2006.01652.x","article-title":"Safety and efficacy of botulinum toxin type a following long-term use","volume":"13","author":"Naumann","year":"2006","journal-title":"Eur. J. Neurol."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/9\/11\/365\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:48:58Z","timestamp":1760208538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/9\/11\/365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,10]]},"references-count":17,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11]]}},"alternative-id":["toxins9110365"],"URL":"https:\/\/doi.org\/10.3390\/toxins9110365","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,10]]}}}